Ariel Gordon and Yossi Gross, two of our investors, talk about the reasons that led them to play an active role in developing a cure for ALS.

 

NeuroSense Therapeutics CEO, Alon Ben-Noon, discusses ALS, our drug PrimeC, and the novel ALS zebrafish model.

 

The amazing story about how Dr. Niva Russek-Blum, the scientist who spent years screening hundreds of potential drugs for ALS, to no avail, finally found a high-efficacy combination drug in collaboration with NeuroSense Therapeutics.